UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials

Clinical infectious diseases, 2019-04, Vol.68 (8), p.1420-1426

2019

Volltextzugriff (PDF)

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz

Pharmacogenetics and genomics, 2006-03, Vol.16 (3), p.191-198

2006

Volltextzugriff (PDF)

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1

Clinical infectious diseases, 2017-01, Vol.64 (1), p.87-91

2017

Volltextzugriff (PDF)

Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects

ESMO open, 2020-08, Vol.5 (4), p.e000856, Article e000856

2020

Volltextzugriff (PDF)

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials

Clinical infectious diseases, 2017-01, Vol.64 (1), p.87-91

2017

Volltextzugriff (PDF)

European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma

ESMO open, 2020-01, Vol.5 (6), p.e000798-e000798, Article e000798

2020

Volltextzugriff (PDF)

relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients

European journal of clinical pharmacology, 2010-04, Vol.66 (4), p.349-357

2010

Volltextzugriff (PDF)

Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus

Gastroenterology (New York, N.Y. 1943), 2019-02, Vol.156 (3), p.529-533.e4

2019

Volltextzugriff (PDF)

EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors

The oncologist (Dayton, Ohio), 2020-06, Vol.25 (6), p.e976-e981

2020

Volltextzugriff (PDF)

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T‐Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

The oncologist (Dayton, Ohio), 2020-04, Vol.25 (4), p.e709-e715

2020

Volltextzugriff (PDF)

Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2018-02, Vol.66 (4), p.617-631

2018

Volltextzugriff (PDF)

EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia

The oncologist (Dayton, Ohio), 2021-03, Vol.26 (3), p.242-249

2021

Volltextzugriff (PDF)

Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapy

Journal of acquired immune deficiency syndromes (1999), 2007-04, Vol.44 (4), p.417-422

2007

Volltextzugriff (PDF)

Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59°N

AIDS (London), 2006-09, Vol.20 (14), p.1906-1907

2006

Volltextzugriff (PDF)

Antiretroviral treatment for HIV infection: Swedish recommendations 2016

Infectious diseases (London, England), 2017-01, Vol.49 (1), p.1-34

2017

Volltextzugriff (PDF)

Novel clinical trial designs for the development of new antiretroviral agents

AIDS (London), 2012-05, Vol.26 (8), p.899-907

2012

Volltextzugriff (PDF)

Type I Error Considerations in Master Protocols With Common Control in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion

Statistics in biopharmaceutical research, 2022-08, Vol.14 (3), p.349-352

2022

Volltextzugriff (PDF)

Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016

Infectious diseases (London, England), 2017-08, Vol.49 (8), p.561-575

2017

Volltextzugriff (PDF)

Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents

Hepatology (Baltimore, Md.), 2012-12, Vol.56 (6), p.2398-2403

2012

Volltextzugriff (PDF)

Cancer Clinical Trials beyond Pandemic: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion

Statistics in biopharmaceutical research, 2023-04, Vol.15 (2), p.444-449

2023

Volltextzugriff (PDF)

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations

Infectious diseases (London, England), 2016-04, Vol.48 (4), p.251-261

2016

Volltextzugriff (PDF)

Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees N

AIDS (London), 2006-09, Vol.20 (14), p.1906

2006

Volltextzugriff (PDF)

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

The oncologist (Dayton, Ohio), 2019-11

2019

Volltextzugriff (PDF)

Authors' Response to “Early Virologic Rebound in a Pilot Trial of Ritonavir-Boosted Atazanavir as Maintenance Monotherapy”

Journal of acquired immune deficiency syndromes (1999), 2007-09, Vol.46 (1), p.118-119

2007

Volltextzugriff (PDF)

Green tea can reduce the effect of Waran

Läkartidningen, 2008-06, Vol.105 (24-25), p.1859

2008

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(40)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(24)
Medicin Och Hälsovetenskap
(23)
Infectious Diseases
(20)
Biological And Medical Sciences
(11)
Hiv Infections - Drug Therapy
(11)
Medical Sciences
(11)
Sweden
(11)
Female
(9)
Human Viral Diseases
(9)
Infectious Medicine
(9)
Infektionsmedicin
(9)
Viral Diseases
(9)
Drug Therapy
(8)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(8)
Clinical Medicine
(7)
Hiv
(7)
Immunodeficiencies
(7)
Immunodeficiencies. Immunoglobulinopathies
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1

Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials

European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma

relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients

Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus

EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T‐Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis

EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia

Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapy

Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59°N

Antiretroviral treatment for HIV infection: Swedish recommendations 2016

Novel clinical trial designs for the development of new antiretroviral agents

Type I Error Considerations in Master Protocols With Common Control in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion

Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016

Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents

Cancer Clinical Trials beyond Pandemic: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations

Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees N

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

Authors' Response to “Early Virologic Rebound in a Pilot Trial of Ritonavir-Boosted Atazanavir as Maintenance Monotherapy”

Green tea can reduce the effect of Waran

Suchergebnisse filtern